(Press-News.org) NEW ORLEANS—A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one centimeter, according to results from a pilot clinical study. The agent, 68Ga-aGPC3-scFv, coded as XH06, was shown to be safe, well-tolerated, and effective at providing high-contrast images of GPC3-positive liver tumors, offering a promising new tool for early diagnosis and staging of HCC—one of the most lethal forms of liver cancer. This research was presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting.
HCC is the sixth most common cancer and the third leading cause of cancer-related deaths globally, accounting for 75–85 percent of all primary liver cancers. Due to its often silent progression, HCC is frequently diagnosed at an advanced stage, contributing to a five-year survival rate of just 18 percent. Most cases arise in the context of chronic hepatitis or liver cirrhosis, where underlying liver damage and fibrosis make early tumor detection particularly challenging.
“While current imaging and diagnosis of HCC primarily depend on contrast-enhanced CT or MRI to identify structural changes, PET imaging has the potential to reveal early molecular alterations that precede visible anatomical shifts,” noted Mengting Li, PhD, attending physician at the Nuclear Medicine Department of Wuhan Union Hospital, in Wuhan, Hubei, China. “Our study concentrated on imaging glypican-3 (GPC3), a cell surface receptor that is overexpressed in most hepatocellular carcinomas and represents a highly specific target for molecular diagnostics and imaging.”
Thirty-six patients with suspected HCC underwent 68Ga-XH06 PET/MR scans. Tumor uptake was measured, and tumor-to-liver ratios were calculated. Pharmacokinetics were assessed by analyzing tracer distribution in various organs, and safety was monitored through lab tests and vital signs. Surgical pathology was performed afterward to confirm HCC diagnoses.
68Ga-aGPC3-scFv was successfully administered to patients with no adverse effects reported. The imaging showed low background activity except for kidney accumulation, and the tracer effectively detected HCC lesions—including tumors smaller than one centimeter—with high contrast. Compared to pathology, the tracer demonstrated sensitivity of 90.63 percent and specificity of 100 percent. Tumor uptake values increased over time, confirming the probe’s specificity and strong imaging performance.
“GPC3-targeted immunoPET provides clearer, more accurate imaging with high tumor-to-background contrast, enabling earlier diagnosis and better staging,” said Xiaoli Lan, MD, PhD, chairwoman of Department of Nuclear Medicine at Wuhan Union Hospital. “For patients, this could mean life-saving interventions at earlier stages, improved treatment planning, and ultimately, higher survival rates. This breakthrough represents a new era in HCC diagnostics, and we are committed to accelerating its global translation, bringing earlier detection and better survival to liver cancer patients worldwide.”
Abstract 252173. “GPC3-targeted immunoPET allows for early detection of HCC: a pilot clinical study,” Mengting Li, Wenzhu Hu, Xiao Zhang, Rui An, Yongxue Zhang, Xiong Cai, Dawei Jiang, and Xiaoli Lan, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China.
Link to Abstract
###
All 2025 SNMMI Annual Meeting abstracts can be found online.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
END
ImmunoPET tracer enhances early detection of liver cancer
2025-06-23
ELSE PRESS RELEASES FROM THIS DATE:
AI-based brain-mapping software receives FDA market authorization
2025-06-23
A new AI-based technology that rapidly maps the brain to locate sensitive areas that control speech, vision, movement and other critical functions has received authorization from the Food and Drug Administration (FDA), enabling it to be marketed to hospitals with the aim of enhancing the precision of neurosurgeries. The technology was developed by researchers and clinicians at Washington University School of Medicine in St. Louis to more precisely guide neurosurgeons in performing delicate brain surgeries to remove tumors or treat epilepsy, for example.
The Cirrus Resting ...
New PET tracer identifies diverse invasive mold infections behind life-threatening illnesses in cancer and transplant patients
2025-06-23
NEW ORLEANS (June 23, 2025)—A novel PET radiotracer can accurately detect a wide range of mold species that are linked to dangerous infections, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting. The imaging agent has the potential to dramatically enhance the diagnosis and monitoring of invasive mold infections in patients.
Advances in cancer and immunosuppressive treatments have helped many patients live longer, but they also leave more people with weakened immune systems, making invasive mold ...
Current Pharmaceutical Analysis (CPA) achieves notable impact factor growth in latest journal citation reports
2025-06-23
In 2025-06-18, the highly anticipated 2024 Journal Citation Reports (JCR) were released, revealing significant progress for the journal Current Pharmaceutical Analysis (CPA). The journal has achieved an impact factor of 1.5, marking a remarkable doubling from the previous year. This accomplishment underscores CPA's growing academic influence and recognition within the field of pharmacology and pharmacy.
The impact factor, a core metric for evaluating a journal's academic impact, reflects the average ...
AI chatbot safeguards fail to prevent spread of health disinformation
2025-06-23
Embargoed for release until 5:00 p.m. ET on Monday 23 June 2025
Follow @Annalsofim on X, Facebook, Instagram, threads, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. ...
UTIA researcher to receive award from the Soil and Water Conservation Society
2025-06-23
Sindhu Jagadamma, associate professor of soil science at the University of Tennessee Institute of Agriculture, will receive the Soil and Water Conservation Society’s 2025 Conservation Research Award at the society’s annual conference in August.
Soil health is critical for sustainable food production, and Jagadamma’s research in her Sustainable Soil Management Lab are developing ways to mitigate soil and environmental problems associated with conventional farm management practices. Her team studies how to maintain soil health through the implementation of conservation management, ...
HSE linguists study how bilinguals use phrases with numerals in Russian
2025-06-23
Researchers at HSE University analysed over 4,000 examples of Russian spoken by bilinguals for whom Russian is a second language, collected from seven regions of Russia. They found that most non-standard numeral constructions are influenced not only by the speakers’ native languages but also by how frequently these expressions occur in everyday speech. For example, common phrases like 'two hours' or 'five kilometres’ almost always match the standard literary form, while less familiar expressions—especially ...
Cold winters halt the northward spread of species in a warming climate
2025-06-23
As the climate warms, many species are shifting northward into areas that were previously too cold for them. A new study on the wall brown butterfly, published in the scientific journal PNAS, shows that rapid evolution can aid this process – but only up to a point. Cold winters stop further expansion beyond certain climatic limits.
“Our results show that even though the butterflies adapt their life cycle as they move northwards, there are limits that evolution cannot easily overcome,” says Mats Ittonen, one of the lead authors of the study done by researchers at the Department of Zoology, Stockholm University.
The wall brown (Lasiommata ...
Study finds early signs of widespread coastal marsh decline
2025-06-23
Researchers have revealed the declining health of coastal marshes several years before visible signs of decline, providing an early warning and opportunity to protect an ecosystem that serves as the first line of defense against coastal flooding.
Scientists from Colorado State University, the University of Georgia and the University of Texas at Austin developed a model to detect early signs of marsh decline using satellite observations. The model identified vulnerable marshes along Georgia’s coast by ...
Massive burps of carbon dioxide led to oxygen-less ocean environments in the deep past
2025-06-23
New research from the University of California, Davis, the Chinese Academy of Sciences and Texas A&M University reveals that massive emissions, or burps, of carbon dioxide from natural earth systems led to significant decreases in ocean oxygen concentrations some 300 million years ago.
Combining geochemical analyses of sediment cores and advanced climate modeling, the study, published June 23 in Proceedings of the National Academy of Sciences, highlights five periods when significant decreases in ocean oxygen levels (by 4% to 12%) coincided with significant increases ...
US muslims’ attitudes toward psychedelic therapy
2025-06-23
A new study in the peer-reviewed journal Psychedelic Medicine demonstrated in this sample that Muslims living in the United States (MLUS) showed moderate openness to psychedelics in mental health therapy. Click here to read the article now.
MLUS have a history of rejecting mental health services. Syed Fayzan Rab, MD, a researcher at the Emory Center for Psychedelics and Spirituality, and coauthors of the study, reported a weak negative correlation between rejection attitudes toward mental health and acceptance of psychedelics.
“Moderate openness to psychedelics ...